10.1002/ejic.202100653
European Journal of Inorganic Chemistry
FULL PAPER
for two days. A solution of NH4OH (10%) was subsequently added for the
quenching. The organic product was extracted three times with
dichloromethane, then it was washed with water and brine, dried over
Na2SO4 and filtered. Lastly, the solvent was removed under reduced
the electronic and photophysical properties of Cu(I) complexes,
which is a challenge that has to be overcome to pursue a more
sustainable chemistry.
pressure.
5: White powder. 179 mg (Yield: 71%) 1H-NMR (400 MHz, CD2Cl2) δ 8.04
– 8.00 (m, 2H), 7.96 (s, 1H), 7.84 – 7.80 (m, 2H), 7.75 (dddd, J = 16.6, 8.4,
7.0, 1.7 Hz, 2H), 7.44 – 7.39 (m, 2H), 7.35 – 7.30 (m, 1H), 5.93 (s, 2H),
2.81 (s, 3H).13C-NMR (126 MHz, CDCl3) δ [ppm] = 152.78 (Cq), 148.22
(Cq), 142.10 (Cq), 140.75 (Cq), 130.73 (+, CArH), 130.38 (Cq), 129.67 (+,
CArH), 129.10 (Cq), 128.85 (+, CArH), 128.58 (Cq), 128.30 (+, CArH), 125.75
(+, CArH), 54.06 (–, CH2), 22.48 (+, CH3). HRMS m/z (C18H15N5): 301.1327
(calc); 301.1326 (found).
Experimental Section
Synthesis
Synthesis of 2-(bromomethyl)-3-methylquinoxaline (9): Bromobutane-
2,3-dione (0.279 g, 1.85 mmol, 1.00 equiv) was dissolved in 5 mL MeOH,
followed by ammonium chloride (49 mg, 0.93 mmol, 0.50 equiv) and 1,2-
phenylendiamine (0.200 g, 1.85 mmol, 1.00 equiv). The reaction mixture
was stirred at room temperature for 30 minutes. Then water was added
and the organic products were extracted with dichloromethane (3 times).
The organic phase collected was washed with brine, dried over Na2SO4,
and filtered. The solvent was removed under vacuum. The product was
used without any further purification for the next step, since the 1H-NMR
analysis revealed the product was clean. The product was a light brown
solid. 328 mg. (Yield:75%) 1H-NMR (400 MHz, CDCl3) δ [ppm] = 8.06 –
8.00 (m, 2H), 7.77 – 7.70 (m, 2H), 4.76 (s, 2H),2.89 (s, 3H). 13C-NMR (126
MHz, CDCl3) δ [ppm] = 153.24 (Cq), 150.98 (Cq), 142.09 (Cq), 140.95 (Cq),
130.58 (+, CArH), 129.61 (+, CArH), 129.14 (+, CArH), 128.53 (+, CArH),
31.94 (–, CH2), 22.57 (+, CH3).
6: White powder. 130 mg (Yield: 55%) 1H-NMR (300 MHz, CD2Cl2) δ 8.30
(s, 1H), 8.22 – 8.09 (m, 2H), 7.99 (d, J = 7.8 Hz, 1H), 7.88 – 7.74 (m, 2H),
7.72 – 7.56 (m, 2H), 7.33 (d, J = 8.5 Hz, 2H), 7.09 (d, J = 7.7 Hz, 1H), 5.93
(s, 2H). 13C-NMR (126 MHz, CDCl3) δ [ppm] = 154.78 (Cq), 148.58 (Cq),
147.80 (Cq), 137.96 (+, CArH), 130.58 (Cq), 130.40 (+, CArH), 129.33 (+,
CArH), 128.97 (+, CArH), 128.37 (+, CArH), 127.88 (+, CArH), 127.73 (Cq),
127.35 (+, CArH), 125.87 (+, CArH), 120.34 (+, CArH), 119.82 (+, CArH),
56.63 (–, CH2). HRMS m/z (C18H14N4): 286.1218 (calc); 286.1218 (found).
7: Greenish powder. 204 mg (Yield: 46%) 1H NMR (400 MHz, CD2Cl2) δ
8.14 (dd, J = 8.2, 1.6 Hz, 1H), 8.11 – 8.07 (m, 1H), 7.92 (s, 1H), 7.87 –
7.76 (m, 4H), 7.67 (dd, J = 6.7, 3.0 Hz, 2H), 7.59 (q, J = 3.2, 2.6 Hz, 3H),
7.42 (t, J = 7.5 Hz, 2H), 7.33 (t, J = 7.4 Hz, 1H), 5.92 (s, 2H).13C-NMR (126
MHz, CDCl3) δ [ppm] = 154.15 (Cq), 147.57 (Cq), 141.94 (Cq), 141.20 (Cq),
137.43 (Cq), 131.12 (+, CArH), 130.77 (Cq), 130.58 (+, CArH), 129.83 (+,
CArH), 129.51 (+, CArH), 129.28 (Cq), 129.21 (+, CArH), 129.18 (+, CArH),
128.96 (+, CArH), 128.28 (+, CArH), 125.87 (+, CArH), 53.67 (–, CH2).HRMS
m/z (C23H17N5): 363.1484 (calc); 363.1483 (found).
Synthesis of 2-(bromomethyl)quinoline (10): According to a modified
procedure,[14] 2-methyl-quinoline (0.500 g, 3.49 mmol, 1.00 equiv) was
reacted with N-bromsuccinimide (1.236 g, 6.98 mmol, 2.00 equiv.) and
benzoylperoxide (0.339 g, 1.39 mmol, 0.40 equiv.) in acetonitrile under
argon atmosphere. The reaction mixture was left under stirring, at 90 °C
for 25 h. Water was afterwards added for the quenching and the product
was extracted successively with dichloromethane (3 times), dried over
Na2SO4, and filtered. The solvent was removed under reduced pressure.
The crude product was purified by silica gel chromatographic column using
the Cy:EtOA=(95:5) as eluent. 105 mg (Yield: 13%) 1H-NMR (300 MHz,
CDCl3) δ [ppm] = 8.20 (t, J = 8.8 Hz, 1H), 8.07 (dq, J = 8.5, 1.0 Hz, 1H),
7.86 – 7.78 (m, 1H), 7.74 (ddt, J = 8.4, 6.9, 1.5 Hz, 1H), 7.63 – 7.52 (m,
2H), 4.72 (s, 2H).
Synthesis of the dichelating ligand 8: According to a modified procedure,
the dibrominated starting ligand 12 (0.270 g, 0.88 mmol, 1.00 equiv) was
dissolved into a 25 mL solution of ethanol and water (7:3) and 2 mL
acetonitrile. Then the other reactants were added in the following order:
sodium azide (0.137 g, 2.10 mmol, 2.40 equiv.), sodium ascorbate (0.198
g, 1.00 mmol, 1.14 equiv.), copper sulfate pentahydrate (0.091 g, 0.37
mmol, 0.42 equiv.), sodium carbonate (0.087 g, 1.06 mmol, 1.20 eq),
ethynylbenzene (0.179 mg, 1.75 mmol, 2.00 equiv.). Please, be careful
and use protective equipment when using NaN3, as it can be explosive.
The reaction mixture was left under stirring for two days. Then a NH4OH
(10%) solution was added for quenching the reaction and the organic
product was extracted with dichloromethane (3 times). The organic phase
collected was washed with brine, dried over Na2SO4, filtered. The product
is a brown solid. 203 mg (Yield: 52%) 1H-NMR (400 MHz, CD2Cl2) δ 8.08
(dt, J = 7.0, 3.5 Hz, 2H), 8.04 (s, 2H), 7.83 (dd, J = 9.4, 7.2 Hz, 6H), 7.42
(t, J = 7.5 Hz, 4H), 7.33 (t, J = 7.0 Hz, 2H), 6.12 (s, 4H). 13C-NMR (126
MHz, CDCl3) δ [ppm] = 148.47 (Cq), 148.21 (Cq), 141.87 (Cq), 131.48 (+,
CArH), 130.33 (Cq), 129.36 (+, CArH), 129.01 (+, CArH), 128.52 (+, CArH),
125.91 (+, CArH), 120.76 (+, CArH), 53.52 (–, CH2).HRMS m/z (C26H21N8)
445.1889 (calc); 445.1888 (found).
Synthesis of 2-methyl-3-phenylquinoxaline (13): 2-methyl-3-
phenylquinoxaline was synthesised from phenyl-1,2-propanedione and
1,2-phenylendiamine using the same procedure adopted for 2-
(bromomethyl)-3-methylchinoxaline (9). In this case the crude product was
further purified by silica gel chromatographic column using
Cy:EtOA=(95:5) as eluent. 2.416 g (Yield: 78%). 1H-NMR (300 MHz,
CDCl3) δ [ppm] = 8.17 – 8.09 (m, 1H), 8.09 – 8.01 (m, 1H), 7.79 – 7.69
(m, 2H), 7.69 – 7.61 (m, 2H), 7.57 – 7.44 (m, 3H), 2.78 (s, 3H).
Synthesis of 2-(bromomethyl)-3-phenylquinoxaline (11):
2-methyl-3-phenylquinoxaline was reacted with N-bromsuccinimide and
benzoylperoxide following the same procedure as used for 2-
(bromomethyl)quinoline (10) in order to get the desired product 11. 337 mg
(Yield: 30%) 1H-NMR (300 MHz, CDCl3) δ [ppm] = 8.18 – 8.11 (m, 2H),
7.83 – 7.74 (m, 4H), 7.59 – 7.52 (m, 3H), 4.76 (s, 2H).
General procedure for the synthesis of the mononuclear complexes
1, 2, 3: According to literature,[16] Cu(ACN)4BF4 (1.00 equiv) and DPEPhos
(1.00 equiv) were dissolved in dry dichloromethane in a Schlenk flask
under argon atmosphere.. After 30 minutes, the desired monochelating
ligand 5-7 (1.00 equiv) was added. The reaction mixture was left under
stirring for four hours. Then the solvent was removed under reduced
pressure. The crude product was dissolved in a minimum amount of
dichloromethane and crystallized by a slow diffusion of cyclohexane.
Synthesis of 2,3-bis(bromomethyl)quinoxaline (12):
2,3-bis(bromomethyl)quinoxaline was synthetized using the same
procedure adopted for 2-(bromomethyl)-3-methylchinoxaline, using 1,4-
dibromobutane-2,3-dione as starting material. The product was used
without any further purification for the next step, since the 1H-NMR analysis
revealed the product was clean. The product was a lightly brown solid. 203
mg (Yield: 97 %) 1H-NMR (300 MHz, CDCl3) δ [ppm] = 8.15 – 8.02 (m,
2H), 7.85 – 7.76 (m, 2H), 4.93 (s, 4H). 13C NMR (126 MHz, CDCl3) δ [ppm]
= 151.01 (Cq), 141.72 (Cq), 131.12 (+, CArH), 129.20 (+, CArH), 30.63 (–,
CH2).
1: Yellow powder. 500 mg (Yield: 88%) 1H NMR (400 MHz, CD2Cl2) δ 8.54
(s, 1H), 8.05 (d, J = 8.5 Hz, 1H), 7.99 (dd, J = 8.6, 1.3 Hz, 1H), 7.60 (ddd,
J = 8.4, 6.9, 1.4 Hz, 1H), 7.47 – 7.42 (m, 2H), 7.32 (td, J = 7.8, 1.7 Hz, 2H),
7.25 (dtd, J = 6.2, 5.0, 2.0 Hz, 7H), 7.17 – 6.89 (m, 21H), 6.75 (dtd, J = 8.1,
4.2, 1.6 Hz, 2H), 6.01 (s, 2H), 3.00 (s, 3H). 13C NMR (101 MHz, CD2Cl2) δ
157.98, 157.92, 157.86, 154.23, 148.70, 147.80, 140.00, 134.57, 133.85,
133.77, 133.70, 132.47, 131.67, 130.72, 130.63, 130.55, 130.37, 129.82,
129.45, 129.20, 129.16, 129.11, 129.05, 126.24, 125.54, 124.38, 123.84,
General procedure for the synthesis of the monochelating ligands 5,
6, 7: According to a modified procedure,[32] the monobrominated starting
ligand 9-11 (1.00 equiv) was dissolved into a solution of ethanol and water
(7:3). Then the other reactants were added in the following order: sodium
azide (1.20 equiv), sodium ascorbate (0.562 equiv.), copper sulfate
pentahydrate (0.204 equiv), sodium carbonate (0.084 mg, 1.01 mmol,
0.591 equiv), ethynylbenzene (0.175 g, 1.71 mmol, 1.00 equiv). Please,
be careful and use protective equipment when using NaN3, as it can be
explosive. The reaction mixture was left under stirring at room temperature
120.35, 51.98, 23.42. 31P-NMR (162 MHz, CD2Cl2) δ -13.99. HRMS (ESI)
+
-
902.2232 (z=1) (C54H43Cu1N5O1P2 +). Calcd for C54H43Cu1N5O1P2 BF4 .
Elemental analysis: [C54H43BCu1F4N5O1P2 ]·CH2Cl2 : C = 61.44, H = 4.22,
N = 6.51 (calc.); C = 61.35, H = 4.15, N = 6.57 (found).
2: Brown powder. 322 mg (Yield: 83%) 1H NMR (400 MHz, CD2Cl2) δ 8.51
(s, 1H), 8.47 (d, J = 8.4 Hz, 1H), 8.25 (d, J = 8.6 Hz, 1H), 8.06 (d, J = 8.4
8
This article is protected by copyright. All rights reserved.